4295 articles
California-based ophthalmic medical company Glaukos announced promising topline results from its phase 2a first-in-human clinical trial for GLK-301 (iLution), a sterile topical cream to treat dry eye disease (DED). The cream formulation acts as a depot allowing pilocarpine to be delivered through th
The Tarsus Eyelid Patch, designed by US startup Nictavi for effective and comfortable eye closure, is now available in New Zealand.
The latest Blackfin Razor frames take design to new heights, offering oversized, geometric shapes made ultra-light thanks to micro-mechanical engineering. A 1mm sheet of beta titanium is cut to form a narrow strip that runs along the front profile, creating a light and airy impression. Model Goose B
The New Zealand Regulations Review Committee (RRC) rejected the Royal Australian and New Zealand College of Ophthalmologists’ (RANZCO) complaint about the Optometrists and Dispensing Opticians Board’s (ODOB) specialist optometrist scope of practice – ophthalmic laser surgeries, and its associated pr
To end Australian optometry’s “health data drought”, Optometry Australia (OA) is urging practices to participate in its nationwide data-collection drive.
University of Auckland Professor Helen Danesh-Meyer has been made a Companion of the New Zealand Order of Merit (CNZM) for her services to ophthalmology in the King’s 2023 New Year honours list.
CooperVision’s plastic-neutral initiative, launched in the US 18 months ago and in Australia and New Zealand in the middle of 2022, has prevented the equivalent of more than 100 million plastic bottles from entering the world’s oceans.
Inspired by the reflected light of the ancient stained glass in France’s Angers Cathedral, Caroline Abram’s colourful Karma collection evokes a treasure chest of gemstones. The glasses have a lightness to them thanks to the use of gadrooning, a technique adding a series of decorative convex curves t
Sarah Berman is the new general manager for Macular Degeneration New Zealand (MDNZ), replacing Anna Crane, who stepped down after two years in the role.
The Ocular Therapeutics Conference (OTC) is returning to its pre-Covid, one-day conference format on Sunday 12 February at the University of Auckland’s Grafton Campus.
Years of campaigning, led by consultant ophthalmologist Associate Professor Andrea Vincent from the University of Auckland, have paid off with the Medicines and Medical Devices Safety Authority’s (Medsafe’s) approval of Luxturna (voretigene neparvovec 0.05mg/mL) to treat patients with RPE65-related
In the battle against increasing resistance to antimicrobial drugs, Sydney’s Bacterial Ocular Surveillance System (BOSS) is an epidemiological study designed to help refine topical treatment regimens.